Optimization of osteoporosis treatment - Combination of alfacalcidol and alendronate;Optimierung der osteoporosetherapie - Kombination von alfacalcidol und alendronat

Journal fur Mineralstoffwechsel

Volumn 10, Issue 4, 2003, Pages 17-20

  Dambacher, Maximilian A ^a,c   Schacht, E ^a   Scharla, S H ^b   Lempert, U G ^b  

^a Universitätklinik Balgrist ^*  (Switzerland)

^b UNIVERSITY OF MUNICH   (Germany)

^c BALGRIST UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; ALFACALCIDOL;

BALANCE DISORDER; BONE DENSITY; BONE MINERAL; BONE STRENGTH; COORDINATION; CORRELATION ANALYSIS; DRUG EFFICACY; ELDERLY CARE; FALLING; FRACTURE; HUMAN; MUSCLE FUNCTION; MUSCULOSKELETAL SYSTEM; NEUROMUSCULAR DISEASE; OSTEOPOROSIS; SHORT SURVEY;

EID: 0345307253     PISSN: 10237763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (17)

1. Shiraishi A, Takeda S, Masaki T, Higuchi Y, Uchiyama Y, Kubodera N, Sato K, Ikeda K, Nakamura T, Matsumoto T, Ogata E. Alfacalcidol inhibits bone resorption and stimulates formation in an ovariectomized rat model of osteoporosis: distinct action from estrogen. J Bone Mineral Res 2000; 15: 770-4.
2. Shibata T, Shira-Ishi A, Masaki T, Sasaki A, Masuda Y, Hishiya A, Ishikura N, Higashi S, Uchida Y, Saito M, Ito M, Ogata E, Watanabe K, Ikeda K. Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast precursors in bone marrow. J Bone Miner Res 2002; 17: 622-9.
3. Schacht E. Rationale for treatment of involutional osteoporosis in women and for prevention and treatment of corticosteroid-induced osteoporosis with alfacalcidol. Calcif Tissue Int 1999; 65: 317-27.
4. Dambacher MA, David G, Kneer W, Neff M. Praktische Orthopädie - Osteoporose. In: Hedtmann A, Götte S (Hrg). Steinkopff-Verlag, Darmstadt, 2000; 49-56.
5. 3 (D-hormone) deficiency/resistance with D-hormone and analogs. Osteologie 2001; 10: 28-39.
6. 3 on bone loss by ovariectomy in aged rats. Jpn J Pharmacol 2002; 89: 255-66.
7. Verhaar HJJ, Samson MM, Jansen PAF, de Vreede PL, Manten JW, Duursma SA. Muscle strength, functional mobility and vitamin D in older women. Aging Clin Exp Res 2000; 12: 455-60.
8. Scharla SH, Bawey S, Holle D, Boensch J, Kamilli I, Lempert UG. 1α-Hydroxyvitamin D (Alfacalcidol) hemmt Knochenabbau, steigert Muskelkraft und verbessert die Schmerzsymptomatik bei Patienten mit chronischer Polyarthritis und Osteopenie. Osteologie 2000; 9 (Suppl 1): 79.
9. Gallagher JC, Fowler SE, Detter JR, Sherman SS. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrinol Metab 2001; 86: 3618-28.
10. Sorensen OH, Lund BI, Saitin B, Lund BJ, Anderson RB, Hyorth L, Melson F, Mosekilde L. Myopathy in bone loss of ageing: Improvement by treatment with 1α-hydroxy-cholecalciferol and calcium. Clin Science 1979; 56: 157-61.
11. Gallagher JC, Haynatski G, Fowler S. Calcitriol therapy reduces falls and fractures in elderly women. Calcif Tissue Int 2003; 72: S334.
12. Dukas L, Bischoff HA, Schacht E, Stähelin HB. Signifikante Reduktion der Anzahl Stürze und Stürzender unter Alfacalcidol in einer Population von mobilen Männern und Frauen über 70 - Resultate einer randomisierten plazebokontrollierten Doppelblind-Studie. Osteologie 2003; 12 (Suppl 1): S45.
13. Masud T, Mulcahy B, Thompson AV, Donnelly S, Keen RW, Doyle DV, Spector TD. Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women. Ann Rheum Dis 1998; 57: 346-9.
14. Frediani B, Allegri A, Bisogno S, Marcolongo R. Effects of combined treatment with calcitriol plus alendronate on bone mass and bone turnover in postmenopausal osteoporosis two years of continuous treatment. Clin Drug Invest 1998; 15: 235-44.
15. 3. J Bone Miner Res 2002; 17: 1498-511.
16. Wong M, Lord S, Lu Y, Lakshmanan M, Scheele W. Raloxifene does not affect neuromuscular-related risk factors for falling or the incidence of falls in postmenopausal women with osteoporosis. J Am Geriatr Soc 2000; 48: 44.
17. Bischoff HA, Stähelin HB, Urscheler N, Ehrsam R, Vonthein R, Perrig-Chiello P, Tyndall A, Theiler R. Muscle strength in the elderly: its relation to vitamin D metabolites. Arch Phys Med Rehabil 1999; 80: 54-8.